DB
CLOV icon

Dmitry Balyasny’s Clover Health Investments CLOV Stock Holding History

Dmitry Balyasny’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-116,255
Closed -$205K – 3059
2026
Q1 		$205K Buy
+116,255
New +$252K ﹤0.01% 2697
2025
Q4 		– Sell
-182,217
Closed -$558K – 3142
2025
Q3 		$558K Buy
+182,217
New +$520K ﹤0.01% 2354
2025
Q2 		– Sell
-395,369
Closed -$1.42M – 2887
2025
Q1 		$1.42M Sell
395,369
-42,691
-10% -$171K ﹤0.01% 1852
2024
Q4 		$1.38M Buy
438,060
+351,241
+405% +$1.26M ﹤0.01% 1817
2024
Q3 		$245K Buy
+86,819
New +$199K ﹤0.01% 2507
2024
Q1 		– Sell
-59,974
Closed -$57.1K – 2679
2023
Q4 		$57.1K Buy
+59,974
New +$58.9K ﹤0.01% 2405
2023
Q2 		– Sell
-579,191
Closed -$489K – 2333
2023
Q1 		$489K Buy
579,191
+539,008
+1,341% +$590K ﹤0.01% 1960
2022
Q4 		$37.4K Sell
40,183
-170,926
-81% -$228K ﹤0.01% 2391
2022
Q3 		$359K Buy
+211,109
New +$553K ﹤0.01% 2135
2022
Q1 		– Sell
-170,027
Closed -$633K – 2514
2021
Q4 		$633K Sell
170,027
-12,827
-7% -$78.7K ﹤0.01% 1564
2021
Q3 		$1.35M Buy
+182,854
New +$1.56M 0.01% 1256
2021
Q2 		– Sell
-71,511
Closed -$541K – 2011
2021
Q1 		$541K Buy
+71,511
New +$807K ﹤0.01% 1382

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Dmitry Balyasny's CLOV Position: Q2 2026 in Review

Dmitry Balyasny sold out of Clover Health Investments (CLOV) in Q2 2026, closing a stake of 116,255 shares — an estimated $205K sold.

Dmitry Balyasny first reported a position in CLOV in Q1 2021 and held it in 12 quarters. The position peaked at $1.42M in Q1 2025. 224 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Dmitry Balyasny reported no remaining Clover Health Investments position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 116,255 Clover Health Investments shares in Q2 2026, an estimated $205K.
  • Dmitry Balyasny first reported a position in Clover Health Investments in Q1 2021 and held it in 12 quarters.
  • Dmitry Balyasny's Clover Health Investments position peaked at $1.42M in Q1 2025.
  • 224 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.